- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04942470
Effect of Aloe Vera and Propolis on Wound Healing in Pressure Injuries
Phd Candidate/Specialist Surgery Nurse
This study was planned as an experimental study with a randomized control group to determine the effect of Aloe Vera and Propolis on wound healing in pressure injuries.
After receiving ethical approval, this study will take place between January 30, 2021 and January 30, 2022 in the General Intensive Care Unit of The Haydarpasa Numune Training and Research Hospital of the Istanbul Provincial Health Directorate, according to the criteria for inclusion and exclusion. The purpose of the research will be explained and it will be selected in accordance with the research criteria from individuals in the universe who have been granted permission by themselves or their guardians to participate in the post-information research. Within the scope of the planned study, an academic study containing aloe vera and propolis cream for patients with pressure injury and reporting the sample size to be used to determine the effect of the solution prepared by the researcher on wound healing (1) In the light of study , standard deviations for groups, respectively, in order to find a statistical difference of 20.4 days (50.5 days) from the 63.2 ± taken as the average wound healing time in pressure injuries; If 20,4 and 15 are taken, the effective sample size calculated for double-sided Student's t test for 0.05 error level and minimum 80% power is calculated as 33 for each group and a total of 66 patients will be admitted to the trial and control group. Patients who meet the study criteria will be distributed daily to experimental and control groups through a computerized randomization program.After randomization, in order to collect data, developed by the researcher in line with the relevant literature information; 'Patient Diagnostic Form', 'Braden Pressure Injury Risk Assessment Scale', 'Bates-Jensen Wound Assessment Tool' and 'Wound Surface 3D Assessment System (Ekare/inSight®)' will be used for wound measurement.In the collection of the data of the patients in the experimental and control group, the patient will be accepted according to the criteria of inclusion and exclusion in the research. 'Patient Diagnostic Form', 'Health History', 'Patient Measurements (Life Findings and Laboratory Findings)' will be questioned and recorded in the experimental and control group patients. The total scores of the test group patients will be recorded by performing a risk assessment with the pressure wound, 'Braden Pressure Injury Risk Assessment Scale'. With the 'Bates-Jensen Wound Assessment Tool', the physiological characteristics of the wound and the condition of the wound will be measured and recorded by performing wound staging. With ekare/inSight® device, wound staging will be performed by photographing the wound area, at the same time the healing status of the wound will be monitored and the reduction in wound volume, i.e. healing, will be observed. With ekare/inSight® device, the healing stages of the wound will be recorded. In the 'Braden Pressure Injury Risk Scale Assessment', the scores and total scores of the patients in the 'Braden Pressure Injury Risk Scale Assessment' will be recorded on the one day, the fourth day, the seventh day, the fourteenth day and twenty-first days by evaluating the substances 'emotional perception', 'humidity', 'activity', 'mobilization', 'nutrition', 'friction/tearing'. Pressure injury risk status and recovery status of the test and control group patients will be measured by Bates-Jensen scores and Braden scores and evaluated on the one day, fourth day, seventh day, fourteen days and twenty-first days. In addition, the date of the wound culture and wound culture results will be recorded as the wound healing time of the patients in the experimental and control group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This research was planned as a randomized controlled experimental research to determine the effect of Aloe Vera and Propolis on wound healing in pressure injuries.
According to the European Pressure Injuries Advisory Panel (EPUAP) definition, pressure injuries alone are localized skin and/or subsurned tissue damage caused by pressure by pressure or tearing, usually occuring on bone protrusions (2).
Pressure injuries that we often encounter in the intensive care unit cause significant problems such as pain and discomfort, low movement and addiction in patients, increased mortality and morbidity, as well as a significant increase in the cost of health care in addition to loss of work and time (1).
Despite recent advances in wound care products, traditional treatments based on naturally sourced compounds such as plant extracts, honey and larvae remain important as alternative treatment options today. Today's trend is more towards the development of innovative wound care treatments, combining the use of traditional healing agents and modern products/applications.
In one study, they developed a transparent treatment by adding aloe vera to alginate hydrogels, propolis to dressing films, and layers of hydrogel containing honey (3). Studies have found that Aloe vera has an effect on the wound healing process as well as its antioxidant, antibacterial, antifungal, antiviral, and immunomodulatory effects. Anti-inflammatory and antimicrobial activities; It facilitates wound healing by stimulating cell proliferation, collagen synthesis and angiogenesis and accelerating wound contraction (3;4).
In the literature, it is mentioned that propolis has antioxidant, anti-inflammatory and antibacterial activity on wound healing within alternative treatment methods.
In a study conducted on experimental animals titled "Wound Healing Activity of Western Algerian Propolis", they formed three groups. In this study where the treatment period was 23 days, the percentage of wound closure was 94.93 ± 5.29% in the first group where propolis was applied, 79.97 ± 13.01% in the second group where a commercial cream was applied, and 72.55 ± 19.94% in the third group without any application. In addition, it was observed that the wound healed in 12 days in the first group, 16 days in the second group and 18 days in the third group. As a result of this study, it was found that the rate of recovery was higher and faster in the group treated with propolis (5).
In addition to studies examining the effectiveness of aloe vera and propolis separately on wound healing, in a study in which they were applied together, their study on 'Medicinal Plant Extracts and the Use of Wound Closure Substances', active ingredients of various herbs such as Propolis and Aloe vera in wound healing and tissue regeneration reported that it can be used to induce the process of wound closure and thus reduce the time to complete wound closure (7). In addition, it is stated in various studies and literature that Aloe vera and propolis may be effective in pressure injuries, which are of great importance in chronic wounds (3; 6; 7).
This study will set an example for pressure injuries with chronic wounds, speeding up the healing time of the patient's wound area, early discharge, reducing maintenance costs and other studies.In the light of these resources, the approval of the institution was obtained from the Istanbul Provincial Health Directorate and pilot work was started on 11.03.2021. Patients were randomized and the data collection phase started.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
İstanbul, Turkey, 34067
- Haydarpasa Numune Training and Research Hospital
-
İstanbul, Turkey, 34186
- Bahcelievler State Hospital
-
İstanbul, Turkey, 34810
- Medipol University
-
-
İstanbul
-
Üsküdar, İstanbul, Turkey, 34067
- Haydarpasa Numune Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- To agree verbally and in writing to participate in the research by himself or his legal guardian after the information for the research,
- Being 18 years of age or older,
- During the pressure wound stages of the participant in the study; Patients with stage II-III pressure sores
- The patients with iskial, sacral, thoracenthers, shoulder, dorsal, heel, malleos, pretibial, elbows, scapula, occiputal, the other regions that may form pressure injury to the body will be included in the study.
Exclusion Criteria:
- Those who have an allergic reaction to the solution to be applied,
- Individuals under the age of 18,
- Patients with Stage Ive IV pressure sores,
- If the patient is included in the study, it will be left out of the study if it loses life during the twenty-day period.
- Patients who do not agree to participate in the research verbally and in writing by themselves or their legal guardian after the information for the research will be excluded from the research.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental:Intervention Arm
For the experimental group patients, sponges prepared by impregnating cream containing Aloe Vera and Propolis will be sterilized in the sterilization device.
If any contamination occurs in the wound area of the patient (in the presence of feces, discharge), the product is applied to the wound bed after cleaning the wound with 0.9% isotonic sodium chloride washing solution.
And the effects of the product on the wound will be monitored.
The solution will be applied 2 times a day for the first 10 days.
The second 10 days will be applied daily 1x1.
Application results will be recorded and wound healing status will be monitored.
In order to prevent and maintain pressure injury, the experimental group patients will be given an in-bed position every 2 hours.
If there is a deficiency or deterioration in the patient's laboratory findings (hemoglobin, albumin, prealbumin, leukocyte, blood sugar, SaO2, fever, pulse, blood pressure, etc.), necessary treatment and care is performed.
|
Suitable of sterile pads containing aloe vera and propolis to the area with pressure sores
|
No Intervention: No Intervention:Control Arm
In control group patients, if any pollution occurs in the wound area (feces, discharge) in the sterile dressing performed in the morning and evening at 10-22 hours, the wound area will be cleaned with the help of 0.9% isotonic sodium chloride washing solution and the clinical routine application of the pressure injury of the hospital will be carried out according to the physician's order.
In patients in the control group, the results of the application will be recorded and wound healing status will be observed.
An in-bed position will be given every 2 hours for the prevention and care of pressure injury patients of the control group patients.
If there is a deficiency or deterioration in the patient's laboratory findings (hemoglobin, albumin, prealbumin, leukocyte, blood sugar, SaO2, fever, pulse, blood pressure and other), the necessary treatment and care will be performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Braden Pressure Injury Risk Scale Assessment
Time Frame: Day one scores
|
Braden Pressure Injury Risk Scale Assessment
|
Day one scores
|
Braden Pressure Injury Risk Scale Assessment
Time Frame: Fourth day scores
|
Braden Pressure Injury Risk Scale Assessment
|
Fourth day scores
|
Braden Pressure Injury Risk Scale Assessment
Time Frame: Seventh day scores
|
Braden Pressure Injury Risk Scale Assessment
|
Seventh day scores
|
Braden Pressure Injury Risk Scale Assessment
Time Frame: Fourteenth day scores
|
Braden Pressure Injury Risk Scale Assessment
|
Fourteenth day scores
|
Braden Pressure Injury Risk Scale Assessment
Time Frame: Twenty-first day scores
|
Braden Pressure Injury Risk Scale Assessment
|
Twenty-first day scores
|
Bates-Jensen Wound Assessment Tool Scores
Time Frame: Day one scores
|
Bates-Jensen Wound Assessment Tool Scores
|
Day one scores
|
Bates-Jensen Wound Assessment Tool Scores
Time Frame: Fourth day scores
|
Bates-Jensen Wound Assessment Tool Scores
|
Fourth day scores
|
Bates-Jensen Wound Assessment Tool Scores
Time Frame: Seventh day scores
|
Bates-Jensen Wound Assessment Tool Scores
|
Seventh day scores
|
Bates-Jensen Wound Assessment Tool Scores
Time Frame: Fourteenth day scores
|
Bates-Jensen Wound Assessment Tool Scores
|
Fourteenth day scores
|
Bates-Jensen Wound Assessment Tool Scores
Time Frame: Twenty-first day scores
|
Bates-Jensen Wound Assessment Tool Scores
|
Twenty-first day scores
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one hemoglobin measurement results (g/dL)
|
Hemoglobin measurement results (g/dL)
|
Day one hemoglobin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day hemoglobin measurement results (g/dL)
|
Hemoglobin measurement results (g/dL)
|
Fourth day hemoglobin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day hemoglobin measurement results (g/dL)
|
Hemoglobin measurement results (g/dL)
|
Seventh day hemoglobin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day hemoglobin measurement results (g/dL)
|
Hemoglobin measurement results (g/dL)
|
Fourteenth day hemoglobin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day hemoglobin measurement results (g/dL)
|
Hemoglobin measurement results (g/dL)
|
Twenty-first day hemoglobin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one albumın measurement results (g/dL)
|
Albumın measurement results (g/dL)
|
Day one albumın measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day albumın measurement results (g/dL)
|
Albumın measurement results (g/dL)
|
Seventh day albumın measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day albumın measurement results (g/dL)
|
Albumın measurement results (g/dL)
|
Fourteenth day albumın measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day albumın measurement results (g/dL)
|
Albumın measurement results (g/dL)
|
Twenty-first day albumın measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one pre-albumin measurement results (g/dL)
|
Pre-albumin measurement results (g/dL)
|
Day one pre-albumin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day pre-albumin measurement results (g/dL)
|
Pre-albumin measurement results (g/dL)
|
Seventh day pre-albumin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day pre-albumin measurement results (g/dL)
|
Pre-albumin measurement results (g/dL)
|
Fourteenth day pre-albumin measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day pre-albumın measurement results (g/dL)
|
Pre-albumin measurement results (g/dL)
|
Twenty-first day pre-albumın measurement results (g/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one glucose measurement results (mg/dL)
|
Glucose measurement results (mg/dL)
|
Day one glucose measurement results (mg/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day glucose measurement results (mg/dL)
|
Glucose measurement results (mg/dL)
|
Fourth day glucose measurement results (mg/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day glucose measurement results (mg/dL)
|
Glucose measurement results (mg/dL)
|
Seventh day glucose measurement results (mg/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day glucose measurement results (mg/dL)
|
Glucose measurement results (mg/dL)
|
Fourteenth day glucose measurement results (mg/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day glucose measurement results (mg/dL)
|
Glucose measurement results (mg/dL)
|
Twenty-first day glucose measurement results (mg/dL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one leukocyte measurement results (10^3/uL)
|
Leukocyte measurement results (10^3/uL)
|
Day one leukocyte measurement results (10^3/uL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day leukocyte measurement results (10^3/uL)
|
Leukocyte measurement results (10^3/uL)
|
Fourth day leukocyte measurement results (10^3/uL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day leukocyte measurement results (10^3/uL)
|
Leukocyte measurement results (10^3/uL)
|
Seventh day leukocyte measurement results (10^3/uL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day leukocyte measurement results (10^3/uL)
|
Leukocyte measurement results (10^3/uL)
|
Fourteenth day leukocyte measurement results (10^3/uL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day leukocyte measurement results (10^3/uL)
|
Leukocyte measurement results (10^3/uL)
|
Twenty-first day leukocyte measurement results (10^3/uL)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one SaO2 measurement results (%)
|
SaO2 measurement results (%)
|
Day one SaO2 measurement results (%)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day SaO2 measurement results (%)
|
SaO2 measurement results (%)
|
Fourth day SaO2 measurement results (%)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day SaO2 measurement results (%)
|
SaO2 measurement results (%)
|
Seventh day SaO2 measurement results (%)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day SaO2 measurement results (%)
|
SaO2 measurement results (%)
|
Fourteenth day SaO2 measurement results (%)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day SaO2 measurement results (%)
|
SaO2 measurement results (%)
|
Twenty-first day SaO2 measurement results (%)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one body temperature measurement results (degrees centigrade)
|
Body Temperature measurement results (degrees centigrade)
|
Day one body temperature measurement results (degrees centigrade)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day body temperature measurement results (degrees centigrade)
|
Body Temperature measurement results (degrees centigrade)
|
Fourth day body temperature measurement results (degrees centigrade)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day body temperature measurement results (degrees centigrade)
|
Body Temperature measurement results (degrees centigrade)
|
Seventh day body temperature measurement results (degrees centigrade)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day body temperature measurement results (degrees centigrade)
|
Body Temperature measurement results (degrees centigrade)
|
Fourteenth day body temperature measurement results (degrees centigrade)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day body temperature measurement results (degrees centigrade)
|
Body Temperature measurement results (degrees centigrade)
|
Twenty-first day body temperature measurement results (degrees centigrade)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one respiratory rate measurement results (.../dak)
|
Respiratory rate measurement results (.../dak)
|
Day one respiratory rate measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day respiratory rate measurement results (.../dak)
|
Respiratory rate measurement results (.../dak)
|
Fourth day respiratory rate measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day respiratory rate measurement results (.../dak)
|
Respiratory rate measurement results (.../dak)
|
Seventh day respiratory rate measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day respiratory rate measurement results (.../dak)
|
Respiratory rate measurement results (.../dak)
|
Fourteenth day respiratory rate measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day respiratory rate measurement results (.../dak)
|
Respiratory rate measurement results (.../dak)
|
Twenty-first day respiratory rate measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one pulse measurement results (.../dak)
|
Pulse measurement results (.../dak)
|
Day one pulse measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day pulse measurement results (.../dak)
|
Pulse measurement results (.../dak)
|
Fourth day pulse measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day pulse measurement results (.../dak)
|
Pulse measurement results (.../dak)
|
Seventh day pulse measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day pulse measurement results (.../dak)
|
Pulse measurement results (.../dak)
|
Fourteenth day pulse measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day pulse measurement results (.../dak)
|
Pulse measurement results (.../dak)
|
Twenty-first day pulse measurement results (.../dak)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Day one blood plessure measurement results (mmHg)
|
Blood Plessure measurement results (mmHg)
|
Day one blood plessure measurement results (mmHg)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourth day blood plessure measurement results (mmHg)
|
Blood Plessure measurement results (mmHg)
|
Fourth day blood plessure measurement results (mmHg)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Seventh day blood plessure measurement results (mmHg)
|
Blood Plessure measurement results (mmHg)
|
Seventh day blood plessure measurement results (mmHg)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Fourteenth day blood plessure measurement results (mmHg)
|
Blood Plessure measurement results (mmHg)
|
Fourteenth day blood plessure measurement results (mmHg)
|
Patient Measurements (Life Findings, Laboratory Values)
Time Frame: Twenty-first day blood plessure measurement results (mmHg)
|
Blood Plessure measurement results (mmHg)
|
Twenty-first day blood plessure measurement results (mmHg)
|
Aloe Vera and Propolis Applied Experimental Group and Control Group, Bates-Jensen Wound Assessment Tool Scores
Time Frame: Score change results between day one and day twenty
|
Aloe Vera and Propolis Applied Experimental Group and Control Group, Bates-Jensen Wound Assessment Tool Scores
|
Score change results between day one and day twenty
|
Aloe Vera and Propolis Applied Experimental Group and Control Group, Braden Pressure Injury Risk Scale Assessment Scores
Time Frame: Score change results between day one and day twenty
|
Aloe Vera and Propolis Applied Experimental Group and Control Group, Braden Pressure Injury Risk Scale Assessment Scores
|
Score change results between day one and day twenty
|
Pressure Wound Recovery Time(Day)
Time Frame: It will be recorded on which day the wound healed within three weeks.
|
Pressure Wound Recovery Time(Day)
|
It will be recorded on which day the wound healed within three weeks.
|
The date the wound culture was taken
Time Frame: For up to three weeks, deep tissue wound culture results will be recorded as (day/month/year).
|
It will be recorded as the date (day / month / year) of the wound culture.
|
For up to three weeks, deep tissue wound culture results will be recorded as (day/month/year).
|
Wound culture results
Time Frame: Culture results for three weeks will be recorded.
|
The infectious agent growing in the wound culture (Deep tissue culture) will be recorded.
|
Culture results for three weeks will be recorded.
|
Socio-demographic characteristics of the patient
Time Frame: Sociodemographic characteristics of patients will be recorded for up to three weeks.
|
Socio-demographic characteristics of the patient
|
Sociodemographic characteristics of patients will be recorded for up to three weeks.
|
Patient health history
Time Frame: This outcome measure includes the patient's health history of existing chronic diseases and any co-morbidities developed during the three-week study period.
|
Patient health history
|
This outcome measure includes the patient's health history of existing chronic diseases and any co-morbidities developed during the three-week study period.
|
Height, Weight
Time Frame: This outcome measure will be used to calculate the patient's body mass index by recording the three-week height and weight measurement results and weight changes over the study period.
|
Height .... cm or Weight .... kg
|
This outcome measure will be used to calculate the patient's body mass index by recording the three-week height and weight measurement results and weight changes over the study period.
|
Body Mass İndeks
Time Frame: This outcome measure will be used to calculate the patient's body mass index by recording the three-week height and weight measurement results and weight changes over the study period.
|
kg/m2
|
This outcome measure will be used to calculate the patient's body mass index by recording the three-week height and weight measurement results and weight changes over the study period.
|
Current disease information and medications used
Time Frame: This outcome measure includes the patient's current chronic disease-related health history, medications used and any comorbidities developed during the three-week study period, and information on medications used during that three-week period.
|
Current disease information and medications used
|
This outcome measure includes the patient's current chronic disease-related health history, medications used and any comorbidities developed during the three-week study period, and information on medications used during that three-week period.
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Avijgan M, Kamran A, Abedini A. Effectiveness of Aloe Vera Gel in Chronic Ulcers in Comparison with Conventional Treatments. Iran J Med Sci. 2016 May;41(3 Suppl):S30.
- Pereira RF, Bartolo PJ. Traditional Therapies for Skin Wound Healing. Adv Wound Care (New Rochelle). 2016 May 1;5(5):208-229. doi: 10.1089/wound.2013.0506.
- Khorasani G, Ahmadi A, Jalal Hosseinimehr S, Ahmadi A, Taheri A, Fathi H. The Effects of Aloe Vera Cream on Split-thickness Skin Graft Donor Site Management: A Randomized, Blinded, Placebo-controlled Study . Wounds. 2011 Feb;23(2):44-8.
- Singh S, Gupta A, Gupta B. Scar free healing mediated by the release of aloe vera and manuka honey from dextran bionanocomposite wound dressings. Int J Biol Macromol. 2018 Dec;120(Pt B):1581-1590. doi: 10.1016/j.ijbiomac.2018.09.124. Epub 2018 Sep 21.
- Medellin-Luna MF, Castaneda-Delgado JE, Martinez-Balderas VY, Cervantes-Villagrana AR. Medicinal Plant Extracts and Their Use As Wound Closure Inducing Agents. J Med Food. 2019 May;22(5):435-443. doi: 10.1089/jmf.2018.0145. Epub 2019 Apr 3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OAydemir1673348861.
- PHD Candidate (Registry Identifier: İSTANBUL UNIVERSITY-CERRAHPAŞA)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcer
-
The Cleveland ClinicRecruitingStage 1 Pressure Ulcer | Stage 2 Pressure UlcerUnited States, Austria
-
University GhentCare of Sweden ABCompletedPressure Ulcer | Pressure Injury | Pressure Ulcer, Buttock | Pressure SoreBelgium
-
Integra LifeSciences CorporationSt Vincent's HospitalCompletedPressure Ulcer | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Our Lady of Maryknoll HospitalWong Tai Sin HospitalUnknownPressure Ulcers Stage III | Pressure Ulcer, Stage IVHong Kong
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Bayside HealthCompletedLength of ICU Stay | Pressure Ulcer, Area | Pressure Ulcer, Grade | Albumin Level | Risk ScoreAustralia
-
University of PittsburghUnited States Department of Defense; Georgia Institute of TechnologyCompletedPressure Ulcer | Pressure Injury | Pressure Ulcer, ButtockUnited States
-
Istituto Ortopedico RizzoliCompleted
-
Istanbul Medipol University HospitalCompletedPressure Ulcers Stage III | Pressure Ulcer, Stage IV
-
Yonsei UniversityUnknownPostoperative Pressure Ulcer
Clinical Trials on Aloe vera and propolis applied
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
-
University of MemphisMannatechCompletedMicrobiome | Immune FunctionUnited States
-
Government College of Dentistry, IndoreUnknown
-
Universidad Autonoma de Nuevo LeonCompleted
-
NHS LothianUniversity of EdinburghWithdrawnInjuries and WoundsUnited Kingdom
-
Cairo UniversityUnknown
-
Ospedale Sandro Pertini, RomaCompletedAloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC)
-
Wake Forest University Health SciencesDesert HarvestNot yet recruitingInterstitial Cystitis | Bladder Pain Syndrome | Chronic Interstitial CystitisUnited States
-
University of NisCompletedDiabetes Type 2Iran, Islamic Republic of
-
Dr. D. Y. Patil Dental College & HospitalCompleted